{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:23:43Z","timestamp":1788920623119,"version":"build-2803163510"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/jcp.0b013e31829e8333","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T11:37:32Z","timestamp":1381145852000},"page":"740-746","source":"Crossref","is-referenced-by-count":75,"title":["Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls"],"prefix":"10.1097","volume":"33","author":[{"given":"Margaret Karolina","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M.S.","family":"Wolever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Arenovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adria","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araba","family":"Chintoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1461145704004171","article-title":"Evidence-based pharmacotherapy of schizophrenia.","volume":"7","author":"Emsley","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"issue":"suppl 1","key":"R2-4-20210128","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease.","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am Heart J"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1192\/bjp.184.47.s64","article-title":"Diabetes mellitus and schizophrenia: historical perspective.","volume":"47","author":"Kohen","year":"2004","journal-title":"Br J Psychiatry Suppl"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10401230209147399","article-title":"Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases.","volume":"14","author":"Jin","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model.","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr Res"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","article-title":"Preclinical models of antipsychotic drug-induced metabolic side effects.","volume":"31","author":"Boyda","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.jcp.0000161501.65890.22","article-title":"Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders.","volume":"25","author":"Kinon","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2337\/diabetes.54.3.862","article-title":"Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs.","volume":"54","author":"Ader","year":"2005","journal-title":"Diabetes"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2008-1815","article-title":"Effects of olanzapine and haloperidol on the metabolic status of healthy men.","volume":"95","author":"Vidarsdottir","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.08m04654yel","article-title":"Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study.","volume":"71","author":"Vidarsdottir","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.npp.1301541","article-title":"Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers.","volume":"33","author":"Sacher","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1210\/jc.2002-021884","article-title":"Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.","volume":"88","author":"Sowell","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-4-20210128","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1210\/jcem.87.6.8599","article-title":"Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.","volume":"87","author":"Sowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/oby.2010.6","article-title":"Increased food intake and energy expenditure following administration of olanzapine to healthy men.","volume":"18","author":"Fountaine","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"R16-4-20210128","doi-asserted-by":"crossref","first-page":"e22662","DOI":"10.1371\/journal.pone.0022662","article-title":"A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers.","volume":"6","author":"Albaugh","year":"2011","journal-title":"PLoS One"},{"key":"R17-4-20210128","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance.","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1172\/JCI112886","article-title":"Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.","volume":"79","author":"Bergman","year":"1987","journal-title":"J Clin Invest"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jcem-70-6-1538","article-title":"A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes.","volume":"70","author":"Finegood","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0091270005283839","article-title":"Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers.","volume":"46","author":"Markowitz","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4088\/JCP.v66n0414","article-title":"Atypical antipsychotics and glucose homeostasis.","volume":"66","author":"Bergman","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"suppl 3","key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","article-title":"The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes.","volume":"32","author":"Bergman","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"R25-4-20210128","first-page":"565","article-title":"Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function.","volume":"22","author":"Gilon","year":"2001","journal-title":"Endocr Rev"},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-1838(95)00101-8","article-title":"Intracerebroventricular injection of methylatropine suppresses insulin response to oral glucose load in rats.","volume":"57","author":"Ohnuma","year":"1996","journal-title":"J Auton Nerv Syst"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1358\/mf.2005.27.5.908643","article-title":"Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.","volume":"27","author":"Silvestre","year":"2005","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/oby.2008.336","article-title":"OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself.","volume":"16","author":"Hucking","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4088\/JCP.09ac05255","article-title":"Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.","volume":"70","author":"Cohen","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy.","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/diacare.19.9.1018","article-title":"Role of glucose effectiveness in the determination of glucose tolerance.","volume":"19","author":"Best","year":"1996","journal-title":"Diabetes Care"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1463-1326.2011.01398.x","article-title":"Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder.","volume":"13","author":"Hardy","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R34-4-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00213-005-0279-x","article-title":"The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.","volume":"185","author":"Cohrs","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00063-003-1255-z","article-title":"Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy.","volume":"98","author":"Meyer","year":"2003","journal-title":"Med Klin"},{"key":"R36-4-20210128","first-page":"626","article-title":"Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue.","volume":"83","author":"Samra","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-4-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.npp.1301142","article-title":"Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis.","volume":"32","author":"Vestri","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance.","volume":"14","author":"Rabe","year":"2008","journal-title":"Mol Med"},{"key":"R39-4-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia.","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet Med"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"Br J Psychiatry"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/070674370605100608","article-title":"Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report.","volume":"51","author":"Cohn","year":"2006","journal-title":"Can J Psychiatry"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/00005768-200009000-00013","article-title":"Changes in physical activity patterns in the United States, by sex and cross-sectional age.","volume":"32","author":"Caspersen","year":"2000","journal-title":"Med Sci Sports Exerc"},{"key":"R43-4-20210128","first-page":"E937","article-title":"Effect of exercise on insulin action, glucose tolerance, and insulin secretion in aging.","volume":"258","author":"Kahn","year":"1990","journal-title":"Am J Physiol"},{"key":"R44-4-20210128","first-page":"534","article-title":"Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study.","volume":"183","author":"McCreadie","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"suppl 1","key":"R45-4-20210128","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1592\/phco.28.9.1198","article-title":"Diabetic ketoacidosis associated with aripiprazole.","volume":"28","author":"Makhzoumi","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2337\/dc08-0441","article-title":"Diabetic ketoacidosis induced by aripiprazole in a 12-year-old boy.","volume":"31","author":"Dhamija","year":"2008","journal-title":"Diabetes Care"},{"key":"R48-4-20210128","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1176\/appi.ajp.159.8.1435","article-title":"Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.","volume":"159","author":"Yang","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.157.6.975","article-title":"Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study.","volume":"157","author":"Henderson","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/070674371005501007","article-title":"Where to position clozapine: re-examining the evidence.","volume":"55","author":"Agid","year":"2010","journal-title":"Can J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e31829e8333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:02:08Z","timestamp":1620943328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201312000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31829e8333","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}